Lucid Registry Study

计划入组 500 人 · 首次发布于 2023 年 7 月 28 日

Capital Mãe

计划入组 446 人

LUCID - LUng Cancer CIrculating Tumour Dna Study

计划入组 100 人 · 首次发布于 2019 年 11 月 6 日

Lucid-201

Lucid-MS

Lucid 21 302

Lucid Diagnostics

United States

Lucid Diagnostics, Inc.

United States

Hercules Capital

United States

Coya Therapeutics Raises $23 Million to Advance ALS Treatment Development

Actuate Therapeutics Raises $17.25 Million to Advance GSK-3β Inhibitor for Difficult-to-Treat Cancers

I-Mab Raises $65 Million to Advance Givastomig Phase 2 Trial for Gastric Cancer